| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.0032 | 1 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | -0.0028 | 1 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.0032 | 1 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | -0.003 | 1 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0029 | 1 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.0028 | 1 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.0025 | 1 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | 0.0026 | 1 |